Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether they lose weight, regain it, or never lose it at all
BCBS is not just one company, but a group of 34 independent insurance companies
The dual GLP-1/GIP receptor agonist DA4-JC shows superior protective properties compared to the GLP-1 analogue Liraglutide in the APP/PS1 mouse model of Alzheimers disease
Medication-related nausea: Usually peaks 24 to 72 hours after an injection and is often triggered by eating specific foods or being overfull
Whether you decide to join us or not, this guide is our way of making sure you know what to expect, how to prepare, and how to navigate the first steps with confidence
Many patients describe this as feeling like the training wheels are coming off